Oregon Health & Science University Dept. Hematologic Malignancies

Portland, Oregon 97239

We've found

1 trials

at this facility

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Status: Enrolling, Phase I
Updated: 10/18/2013

from

Portland, OR

Use our guide to learn which trials are right for you!